Medication list

Peptide therapy medication list: options to review online

A clinician-safe medication list for online peptide therapy, including GLP-1s, sermorelin, PT-141, NAD+, glutathione, GHK-Cu, methylene blue, route differences, FDA-status questions, and seller red flags.

How to read the list

Start with the active ingredient, not the marketing name: semaglutide, tirzepatide, sermorelin, bremelanotide, NAD+, glutathione, GHK-Cu, or methylene blue.

Check the route and format: branded pen or vial, compounded injection, nasal spray, topical foam or cream, oral capsule, troche, or other delivery method.

Separate FDA-approved brand labels from individualized compounded prescriptions; compounded medications are not FDA-approved finished drug products.

Match each option to the medical question: weight management, type 2 diabetes label context, sexual health, longevity interest, skin or scalp goals, energy, recovery, or focus.

Ask what would change the plan: contraindications, medication interactions, pregnancy or surgery timing, labs or vitals, side effects, cost, pharmacy source, and follow-up.

Direct answer

A safe peptide therapy medication list should separate FDA-approved brand medicines, individualized compounded prescriptions, topical or nasal products, and non-prescription supplements or research chemicals. Peptide12-listed options include semaglutide, tirzepatide, Wegovy, Ozempic, Zepbound, Mounjaro, sermorelin, PT-141/bremelanotide, NAD+, glutathione, GHK-Cu topical foam, and low-dose oral methylene blue. Eligibility depends on clinician review.

Listed options

What medications does an online peptide list usually include?

The highest-value list is not the longest list. It should focus on products a clinician can actually evaluate, prescribe, dispense, monitor, or decline. For Peptide12, that means GLP-1 and GIP/GLP-1 options for weight-related care, sermorelin for growth-hormone-axis discussions, PT-141/bremelanotide for sexual-health questions, NAD+ and glutathione for longevity or wellness interest, GHK-Cu topical foam for cosmetic skin or scalp goals, and low-dose oral methylene blue with careful interaction screening.

GLP-1 category: compounded semaglutide, compounded tirzepatide, Wegovy, Ozempic, Zepbound, and Mounjaro each need label, indication, access, side-effect, and pharmacy-quality review.
Non-GLP category: sermorelin, PT-141/bremelanotide, NAD+, glutathione, GHK-Cu, and methylene blue raise different questions about route, evidence limits, medication interactions, labs, or topical tolerance.
A list should not imply that every popular peptide is available, approved, legal for every use, or appropriate for direct purchase without a prescription and clinician evaluation.

Status and route

The same category can include very different regulatory pathways

Patients often compare a brand-name medicine, a compounded prescription, and a supplement-style product as if they are interchangeable. They are not. Brand labels such as Wegovy, Ozempic, Zepbound, Mounjaro, and Vyleesi have FDA-reviewed prescribing information. Compounded prescriptions, when clinically appropriate and allowed, are individualized and should be discussed with pharmacy-quality questions. Supplements and research-use products are separate categories and should not be treated as prescription substitutes.

Ask whether the product is FDA-approved for a labeled use, compounded for an individual patient, off-label, topical cosmetic support, a dietary supplement, or not appropriate for human use.
Ask whether the route changes safety: injectable products need different label, storage, sharps, sterility, and side-effect instructions than nasal, topical, oral, or troche formats.
Avoid sellers that advertise research chemicals for human use, claim “FDA-approved peptides” without naming exact labeled products, or hide pharmacy and prescriber details.

Clinical fit

A medication list is only useful when tied to patient-specific screening

A responsible list should help a patient prepare for clinician review, not self-select a stack. The safer comparison is product-by-product: active ingredient, reason for care, medical history, current medications, allergies, pregnancy or surgery context, lab or vital-sign needs, expected follow-up, cost, refill plan, and what symptoms require urgent care or an in-person clinician.

For GLP-1s, discuss diabetes medicines, GI symptoms, dehydration, kidney, gallbladder, pancreas, thyroid cancer or MEN2 history, pregnancy planning, and branded versus compounded access.
For methylene blue, review serotonergic medicines, opioids, psychiatric medicines, G6PD history, pregnancy context, and why focus or fatigue symptoms are being evaluated.
For sermorelin, PT-141, NAD+, glutathione, and GHK-Cu, review labs or vitals when relevant, blood-pressure or cardiovascular history, route-specific side effects, topical irritation, and realistic expectations.

Patient safety checklist

Questions to ask before choosing from a peptide therapy medication list

These points are educational and do not replace medical advice. A licensed clinician should review individual history, medications, risks, and state-specific availability before treatment.

✓

What is the exact active ingredient, brand or compounded name, route, strength, and intended goal?

✓

Is this an FDA-approved product for a labeled use, an individualized compounded prescription, an off-label discussion, a topical cosmetic product, or a supplement/research product?

✓

What patient history, medication list, allergies, pregnancy plans, surgery timing, vitals, or labs could change eligibility?

✓

What side effects and urgent warning signs are specific to this product category and route?

✓

Who is the licensed clinician making the prescription decision, and can the clinic explain when it would decline or delay care?

✓

Which pharmacy or brand channel dispenses the medication, and are storage, labeling, beyond-use dates, refills, and adverse-event support clear?

✓

What is the total cost, including consult, medication, labs, supplies, shipping, follow-up, membership fees, and cancellation or pause rules?

✓

Does the page or seller avoid guaranteed results, no-prescription checkout, peptide-stack recipes, and dosing charts that bypass clinician review?

FAQs

Short answers for patients

What peptide medications are listed by Peptide12?

Peptide12-listed options include compounded semaglutide, compounded tirzepatide, Wegovy, Ozempic, Zepbound, Mounjaro, compounded sermorelin, PT-141/bremelanotide, compounded glutathione, NAD+ injection, NAD+ nasal spray, NAD+ topical or face cream, GHK-Cu topical foam, and low-dose oral methylene blue. Availability and eligibility depend on clinician review.

Are all peptide therapy medications FDA-approved?

No. Some brand-name products have FDA-approved labels, while compounded prescriptions are not FDA-approved finished drug products and may be used only when clinically appropriate and allowed. Supplements and research chemicals are different categories and should not be treated as prescription medications.

Which peptide medication is best for weight loss?

There is no universal best option. Weight-related discussions usually compare semaglutide or tirzepatide options, including branded Wegovy, Ozempic, Zepbound, Mounjaro, and compounded prescriptions when appropriate. Fit depends on diagnosis, eligibility, contraindications, side effects, coverage, cost, pharmacy access, and clinician judgment.

Can I choose a peptide medication from a list without a doctor?

No. A medication list can help you prepare questions, but prescription decisions should be made by a licensed clinician who reviews health history, medications, risk factors, product status, pharmacy source, and follow-up needs. Avoid no-prescription peptide sellers.

How should I compare compounded and brand-name peptide options?

Compare active ingredient, FDA-approved label status, reason for use, clinician review, pharmacy or manufacturer channel, dosing and route instructions, side-effect plan, cost, insurance or cash-pay access, refills, and follow-up. Do not assume compounded prescriptions are FDA-approved or automatically interchangeable with brand products.

What is a red flag in a peptide medication list online?

Red flags include guaranteed outcomes, no-prescription checkout, research-use products marketed for people, hidden pharmacy sourcing, vague “FDA-approved peptide” language, dosing or stacking charts without medical review, and pressure to buy before eligibility is evaluated.

Sources and related reading

Peptide12 pages use conservative educational language and authoritative sources where possible.

FDA: Human Drug Compounding FDA BeSafeRx: Online pharmacy information MedlinePlus: Drugs, Herbs and Supplements DailyMed: Wegovy (semaglutide) prescribing information DailyMed: Zepbound (tirzepatide) prescribing information DailyMed: Vyleesi (bremelanotide) prescribing information What are peptide medications?Which peptide therapy is right for me?Peptide therapy formats Compounded vs branded peptide medications Peptide pharmacy quality checklist Medication interaction review Peptide therapy cost guide Peptide12: How online peptide therapy works